ConductScience.org, home

Paper2201398

Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.

Wintzer HO and 2 others. Br J Cancer, 1990. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas. Papers, record 2201398. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2201398

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.
PubMed
Journal
Br J Cancer
PubMed
Year
1990
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
1.02
iCite
Revised in PubMed
2019-05-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wintzer HOH O
2Benzing MM
3von Kleist SS

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Histocompatibility Antigens Class IMajor topic
Histocompatibility Antigens Class IIMajor topic
beta 2-MicroglobulinMajor topic
Antigens, Neoplasm
Female
Humans
Immunohistochemistry
Prognosis

Source PubMed

Download CSV of topics

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16605800Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6605800PubMed
23312546Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast.J Pathol1987https://conductscience.org/library/papers/3312546PubMed
36365132Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.Br J Cancer1984https://conductscience.org/library/papers/6365132PubMed
46365133Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.Br J Cancer1984https://conductscience.org/library/papers/6365133PubMed
56366179beta 2-microglobulin in non-malignant and malignant human breast: a feature of differentiation.J Pathol1984https://conductscience.org/library/papers/6366179PubMed
66233227Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes.Int J Cancer1984https://conductscience.org/library/papers/6233227PubMed
76087025Expression of normal and tumor-associated antigens in human breast carcinoma.Lab Invest1984https://conductscience.org/library/papers/6087025PubMed
83416309Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis.Cancer Res1988https://conductscience.org/library/papers/3416309PubMed
93262710Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.J Exp Med1988https://conductscience.org/library/papers/3262710PubMed
102461055Specificity of the T cell receptor for antigen.Adv Immunol1988https://conductscience.org/library/papers/2461055PubMed
113191451Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.Cancer1988https://conductscience.org/library/papers/3191451PubMed
122462591Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma.J Immunol1989https://conductscience.org/library/papers/2462591PubMed
132851231[MHC antigen expression, proliferative activity, and nodal metastasis in 184 invasive ductal breast carcinomas].Verh Dtsch Ges Pathol1988https://conductscience.org/library/papers/2851231PubMed
142649129HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.Br J Cancer1989https://conductscience.org/library/papers/2649129PubMed
152784858Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2784858PubMed
163314998The influence of major histocompatibility complex class I antigens on tumor growth and metastasis.Biochim Biophys Acta1987https://conductscience.org/library/papers/3314998PubMed
173689666Confirmation of a prognostic index in primary breast cancer.Br J Cancer1987https://conductscience.org/library/papers/3689666PubMed
183338038The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.Cancer1988https://conductscience.org/library/papers/3338038PubMed
193501402Auto-tumor immunity in patients with solid tumors: participation of CD3 complex and MHC class I antigens in the lytic interaction.Immunol Lett1987https://conductscience.org/library/papers/3501402PubMed
202895339Selective loss of HLA-A,B,C locus products in colorectal adenocarcinoma.Lancet1988https://conductscience.org/library/papers/2895339PubMed

See all 56 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
39164522Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells.Oncogene2024https://conductscience.org/library/papers/39164522PubMed
35543859Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer.Cell Oncol (Dordr)2022https://conductscience.org/library/papers/35543859PubMed
33767702Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.Front Immunol2021https://conductscience.org/library/papers/33767702PubMed
33257819Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients.Genes Immun2020https://conductscience.org/library/papers/33257819PubMed
21886544Role of the HLA System in the Pathogenesis of Dupuytren's Disease.Hand (N Y)2010https://conductscience.org/library/papers/21886544PubMed
19196481High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study.BMC Cancer2009https://conductscience.org/library/papers/19196481PubMed
16761451Prognostic significance of major histocompatibility complex class II antigens (HLA-DR) in normal colonic mucosa, tubulovillous adenoma, and invasive colonic carcinoma.Ann Saudi Med2006https://conductscience.org/library/papers/16761451PubMed
15387374Immunocytochemical demonstration of down regulation of HLA class-I molecule expression in human metastatic breast carcinoma.Clin Exp Metastasis2004https://conductscience.org/library/papers/15387374PubMed
14528281Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?Oncogene2003https://conductscience.org/library/papers/14528281PubMed
10823125HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.J Clin Pathol2000https://conductscience.org/library/papers/10823125PubMed
10618685The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.Med Oncol1999https://conductscience.org/library/papers/10618685PubMed
8546899Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.Br J Cancer1996https://conductscience.org/library/papers/8546899PubMed
8369118Influence of LAK cells on expression of HLA-DR antigen on laryngeal carcinoma cell line in new culture systems.Eur Arch Otorhinolaryngol1993https://conductscience.org/library/papers/8369118PubMed
7820955Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.Clin Exp Metastasis1995https://conductscience.org/library/papers/7820955PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-B3106PubTator's text mininghttps://conductscience.org/library/genes/3106NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
HLA-G3135PubTator's text mininghttps://conductscience.org/library/genes/3135NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2201398

GET https://conductscience.org/api/papers/v1/2201398/references?page=2